Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2020 | CML management in resource limited countries

Jerald P. Radich • 23 Aug 2020
SOHO 2020
Chronic Myeloid Leukemia Leukemia

Jerald P. Radich, MD, of the University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, discusses the management of chronic myeloid leukemia (CML) in resource-limited countries, including efforts from The Max Foundation, academia, as well as pharmaceutical and biotechnology companies to diagnose and treat patients with CML in developing countries. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Jerald P. Radich

3:59
ENESTnd: results from an exploratory biomarker analysis in CML
Jerald P. Radich • 24 Aug 2020
3:43
The molecular complexity of CML
Jerald P. Radich • 23 Aug 2020

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals